Terms: = Kidney tumors AND Nuclear matrix protein 22 AND Treatment
3 results:
1. Use of the nuclear matrix protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.
Xia CS; Fan CH; Su M; Wang QS; Bao HZ
Dis Markers; 2020; 2020():3424039. PubMed ID: 32454904
[TBL] [Abstract] [Full Text] [Related]
2. [Transurethral flexible ureteroscopic holmium laser resection for tumors of renal pelvis: 6 cases report and literature review].
Hao YC; Chen K; Liu YQ; Lu J; Xiao CL; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):816-821. PubMed ID: 30337741
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
[TBL] [Abstract] [Full Text] [Related]
